Efficacy and Safety of Tocilizumab for TAO

Clinical trial NCT06087731 · WITHDRAWN

Trial details

NCT number: NCT06087731
Sponsor: Sun Yat-sen University
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Tocilizumab Thyroid Associated Ophthalmopathy

Start date: 2023-09-23
Primary completion: 2023-09-23
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.